Untreated sewage has been flowing into stream for 9 months after damage at wastewater treatment plant; local official in ...

Pharmascience Inc. and Teva Canada Ltd. market the nebules and are both reporting shortages due to manufacturing disruptions. Apotex Inc., Sanis Health Inc., Teva Canada Ltd. and GlaxoSmithKline Inc. ...

2025 Free Cash Flow Guidance: $1.6 billion to $1.9 billion. Teva Pharmaceutical Industries Ltd (NYSE:TEVA) reported a 9% increase in revenue for 2024, reaching $16.5 billion, driven by strong ...

Teva Pharmaceutical Industries' Q4 2024 results were strong, but 2025 guidance underwhelmed, causing a sharp stock sell-off. Management's cautious 2025 guidance sets a low bar, likely to be ...

Shares of Teva Pharmaceutical Industries (NYSE: TEVA) were slipping Wednesday. The company's stock lost 13.5% as of 1:15 p.m. ET. The leg down comes as the S&P 500 (SNPINDEX: ^GSPC) and Nasdaq ...

let’s take a look at some background. Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in ...

In their paper the team concluded, “…the provocative implication from our data is that individual cancer susceptibility may have as much to do with the epigenetic ‘background’ we are born ...

Monica is a Newsweek reporter based in Boston. Her focus is reporting on breaking news. Monica joined Newsweek in 2024. She is a graduate of Clark University, with a master's from both Clark ...

The FDA has accepted Alvotech (NASDAQ:ALVO) and Teva's (NYSE:TEVA) Biologics License Applications for AVT05, their proposed biosimilar to the anti-inflammatory drugs Simponi and Simponi Aria.

After years of legal wrangling surrounding Teva’s Copaxone, the latest hit to the lucrative multiple sclerosis drug comes in the form of a safety-related boxed warning. The label update ...

On January 10, 2025, Teva Pharmaceutical Industries Ltd. and Samsung Bioepis Co., Ltd. announced that they entered into a licensing agreement to commercialize EPYSQLI® (eculizumab-aagh), Samsung ...